Ancient herb granule takes on MS in new clinical trial
NCT ID NCT07029867
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests whether a traditional Chinese medicine called Yishen Daluo Yin granule can help people with relapsing-remitting multiple sclerosis. About 152 participants will take either the granule or a placebo twice a day for 24 weeks. The main goal is to see if the treatment reduces new brain lesions and relapses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Yishen Daluo Yin granule (a traditional Chinese medicine)
- What this could lead to
- If it works, this could offer a new treatment option for people with relapsing-remitting multiple sclerosis to reduce brain lesions and relapses.
- What could go wrong
- This is an early-stage trial with 152 participants, so results may not apply to everyone. The treatment is a traditional Chinese medicine, and its effectiveness and safety are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSE REMITTING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.